Regulatory nod to Lundbeck’s drug for alcohol dependence

The European Medicines Agency’s main scientific committee has recommended that a new treatment for alcohol dependence, Selincro (nalmefene), be licensed in Europe. The H. Lundbeck A/S drug is for adults with high rates of alcohol consumption.